Delivery Order SPE2DB22D9209-SPE2DB25FL5RV

The Defense Logistics Agency awarded a $9,813 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4558369217 XOLAIR 150 MG/ML SYRINGEML. The contract has a period of performance from September 1, 2022 through September 23, 2022 and will be performed in Park Ridge, Illinois. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to provide the specified medication in support of DoD health programs. No set aside designation or subcontractors...

The Defense Logistics Agency awarded a $773 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562235601 XOLAIR 150 MG/ML SYRINGEML, to be delivered by October 5, 2023. Xolair is the brand name for omalizumab, a prescription medicine that reduces the amount of antibody IgE in the blood. This delivery order was issued under an existing DLA pharmaceutical supply contract vehicle, with no set-aside designation specified. DMS Pharmaceutical...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a ceiling value of $4,322.04 and a period of performance ending on July 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGE, a specialty pharmaceutical product, with a ceiling value of $5,064.24 and a period of performance through June 10, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....

This delivery order for $23,211 was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562584463 units of XOLAIR 150 MG/ML SYRINGES with a completion date of November 13, 2023. XOLAIR is used to treat allergic asthma and chronic idiopathic urticaria. No set-aside designation was used for this firm fixed price order to supply the pharmaceutical to the Defense Logistics Agency, the agency within the Department of Defense that...

This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 4559523275 units of XOLAIR 150 MG/ML SYRINGEML with a potential value of $9,284.40. The contract has a firm fixed price and is to be completed by January 26, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. will deliver the pharmaceutical products from its location in Park Ridge, Illinois to support the Defense Logistics Agency's medical...

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $7,737 against its indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. The delivery order was awarded on November 2, 2023 and has a completion date of November 27, 2023. The contract vehicle, held with the Defense Logistics Agency Troop Support Medical since December 2025, provides pharmaceutical items and medical supplies with a potential value of up to...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $1,440.70 and a performance period ending on July 17, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen...

The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $386 firm fixed price delivery order for XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The order was awarded on October 4, 2023 under an unspecified contract vehicle and has a period of performance concluding on October 26, 2023. To be delivered to Park Ridge, Illinois, the syringes will support DLA's mission to provide pharmaceuticals and other medical supplies to the U.S. military and other government agencies. No set-aside provision...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a medical product, with a ceiling value of $40,513.92 and a period of performance extending through June 3, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen...